Here are some key areas where it may contribute to our overall health: 1
The brokerage estimates Indias weight-loss market at about $500 million, which could rise to $1 billion with the right pricing, adoption and government incentives. Demand for these weight-loss drugs is also high as Indias 1.4-billion-plus population faces a higher burden of diabetes and cardiovascular ailments, largely due to increasingly sedentary urban lifestyles
Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes
The platform manages enrollment, billing, and coordination but does not employ clinicians or make prescribing decisions
Supplied as a lyophilized powder in a sealed glass vial, 20 mg per vial a higher-concentration variant of the standard 10 mg reference vial